CLINICAL_TRIALS
ClinicalTrials.gov record update
Should Routine Prophylactic Dexamethasone Be Administered Before Intravenous Infliximab in Moderate-to-Severe Inflammatory Bowel Disease: A Prospective, Multicenter, Observational Cohort Study
This page presents selected fields from the linked source record. It does not add a medical interpretation.
Record identity and dates
- Source
- ClinicalTrials.gov
- Source record ID
- NCT07385131
- Title field or adapter rule
- protocolSection.identificationModule.officialTitle
- Ingested At
- 2026-04-25T22:28:31.598752+00:00
- Published At
- 2026-02-03T00:00:00+00:00
- Record Updated At
- 2026-02-03
- Timestamp Basis
- source retrieval time was not retained by the feed adapter
- Date limitation
- source retrieval time was not retained by the feed adapter
Fields recorded by this source
- protocolSection.conditionsModule.conditions
["Inflammatory Bowel Disease (IBD)", "CD - Crohn\u0027s Disease", "UC - Ulcerative Colitis"]- protocolSection.statusModule.lastUpdatePostDateStruct.date
"2026-02-03"- protocolSection.identificationModule.nctId
"NCT07385131"- protocolSection.identificationModule.officialTitle
"Should Routine Prophylactic Dexamethasone Be Administered Before Intravenous Infliximab in Moderate-to-Severe Inflammatory Bowel Disease: A Prospective, Multicenter, Observational Cohort Study"- protocolSection.statusModule.overallStatus
"RECRUITING"- protocolSection.designModule.phases
[]- protocolSection.statusModule.resultsFirstPostDateStruct.date
""
Study condition terms
Intervention details are not present in the imported fields for this record. No drug-condition relationship is inferred from co-listing.
This index keeps the source fields it imported; it may not contain the complete original record. Verify wording and context in the linked source.